Details of the Drug Reposition

General Information of This Drug (ID: DMPO5IC)

• Drug Name: Interleukin-12 gene therapy (DMPO5IC)

Information on Drug Reposition of This Drug

3 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Cutaneous T-cell lymphoma	DISAYSZB	2B01	Phase 2	[1]
Melanoma	DIS1RRCY	2C30	Phase 2	[1]
Merkel cell carcinoma	DISDJJ4U	2C34	Phase 2	[1]

References

• [1] Clinical pipeline report, company report or official report of OncoSec Medical.